Stratec SE
Research Stratec SE (0RAR) on Bullrun: P/E 5.4. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0RAR
- ExchangeLSE
- CountryGermany
- CurrencyEUR
- P/E5.4
Valuation Snapshot
P/E is 5.4.
About Stratec SE
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
Frequently asked questions
What is Stratec SE's P/E ratio?
Stratec SE's price-to-earnings (P/E) ratio is 5.4.
What does Stratec SE do?
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers.